Cause-specific survival of patients with diffuse large B-cell lymphoma... | Download Scientific Diagram
R-EPOCH May Extend Survival in Patients with Rare Forms of Diffuse Large B-Cell Lymphoma – Consult QD
International prognostic indices in diffuse large B-cell lymphoma: a comparison of IPI, R-IPI, and NCCN-IPI - ScienceDirect
Determining Prognosis for Patients With Diffuse Large B-Cell Lymphoma - Hematology Advisor
Factors related to the relative survival of patients with diffuse large B-cell lymphoma in a population-based study in France: does socio-economic status have a role? | Haematologica
Diffuse Large B-Cell Lymphoma (DLBCL): Symptoms, Treatment and Prognosis – Nova Science Publishers
Diffuse large B-cell lymphoma - Wikipedia
DLBCL Prognosis: Fear, Hope, and Understanding Survival Rates | MyLymphomaTeam
2-year survival rates of acute lymphoblastic leukemia, diffuse large... | Download Scientific Diagram
British Journal of Haematology | Wiley Online Library
Diffuse large B-cell lymphoma: 10 years' real-world clinical experience with rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisolone
Ibrutinib improves diffuse large B-cell lymphoma survival - NCI
Overall survival (OS) in all 75 patients with diffuse large B-cell... | Download Scientific Diagram
A Clinico-Genotypic Prognostic Index for De Novo Composite Diffuse Large B-Cell Lymphoma Arising from Follicular Lymphoma in Asian patients treated in the Rituximab Era | Scientific Reports
Overall survival of patients with diffuse large B-cell lymphoma... | Download Scientific Diagram
A) Overall survival of 112 patients with relapsed diffuse large B-cell... | Download Scientific Diagram
Biology Informs Treatment Choices in Diffuse Large B Cell Lymphoma: Trends in Cancer
De novo CD5+ diffuse large B-cell lymphoma: results of a detailed clinicopathological review in 120 patients | Haematologica
Cancers | Free Full-Text | Monoclonal Antibodies in the Treatment of Diffuse Large B-Cell Lymphoma: Moving beyond Rituximab
Diffuse Large B-Cell Lymphoma | NEJM
Treatment resistance in diffuse large B-cell lymphoma | Leukemia
Anthracycline dose optimisation in patients with diffuse large B-cell lymphoma: a multicentre, phase 3, randomised, controlled trial - The Lancet Haematology
